Rapport Therapeutics, Inc. (RAPP) Reports Q4 Loss of $0.72

Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q4 EPS of ($0.72), versus $0.00 reported last year.

For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.

You May Also Be Interested In

• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
• LPA gets Peru antitrust approval for $145M logistics park sale
• Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst